Pfizer triples profits in 2021 Pfizer doubled profits with 22 billion dollars from the sale of its anticovid vaccine for 36 thousand 800 million dollars. By 2022, it plans to sell the vaccine developed with biontech for $32 billion, as well as $22 billion for the antiviral pill to treat the disease.